Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia De Stefano

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2024
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human BloodAlessia De Stefano, Alessandra Cappellini, Irene Casalin, et al.
Advances in Biological Regulation|December 8, 2024
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasmsEleonora Ceneri, Alessia De Stefano, Irene Casalin, et al.
Clinical Epigenetics|February 21, 2023
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromesSara Mongiorgi, Alessia De Stefano, Stefano Ratti, et al.
Advances in Biological Regulation|January 19, 2024
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progressionIrene Casalin, Alessia De Stefano, Eleonora Ceneri, et al.
British Journal of Haematology|March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective studyAleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2024
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human BloodAlessia De Stefano, Alessandra Cappellini, Irene Casalin, et al.
Advances in Biological Regulation|December 8, 2024
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasmsEleonora Ceneri, Alessia De Stefano, Irene Casalin, et al.
Clinical Epigenetics|February 21, 2023
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromesSara Mongiorgi, Alessia De Stefano, Stefano Ratti, et al.
Advances in Biological Regulation|January 19, 2024
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progressionIrene Casalin, Alessia De Stefano, Eleonora Ceneri, et al.
British Journal of Haematology|March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective studyAleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Pageof 2